Disappearance of Serum Hepatitis C Virus RNA within Two Days after One Dose Interferon Administration is Predictive for Response to High-dose Interferon-.ALPHA.2b Treatment for Chronic Hepatitis C.
“…Nucleoside or nucleotide analogues for chronic HBV infection also decrease the incidence of HCC. This outcome has been encouraging to hepatologists and we continue to treat patients with chronic liver diseases as we have done for chronic hepatitis C during the last few decades [105][106][107][108][109][110][111] until HCC is finally eradicated. Table 6 The survival rates of patients with HCC in the JIS score 0-1 RFA: radio frequency ablation therapy, TACE: trasarterial chemo-embolization, PEI: percutaneous ethanol injection therapy.…”
“…Nucleoside or nucleotide analogues for chronic HBV infection also decrease the incidence of HCC. This outcome has been encouraging to hepatologists and we continue to treat patients with chronic liver diseases as we have done for chronic hepatitis C during the last few decades [105][106][107][108][109][110][111] until HCC is finally eradicated. Table 6 The survival rates of patients with HCC in the JIS score 0-1 RFA: radio frequency ablation therapy, TACE: trasarterial chemo-embolization, PEI: percutaneous ethanol injection therapy.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.